אייטוברין - Eyetobrin
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | S01AA Antibiotics |
|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
|
| צ×רת ××ª× | ×¢×× × - OCULAR |
| צ×רת ××× ×× | ××פ×ת ×¢×× ×××, EYE DROPS, SOLUTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× |
| ×ת×××× | EYETOBRIN 0.3 % W/V is indicated for the treatment of external bacterial infections of the eye and its structures, such as conjunctivitis caused by tobramycin-sensitive bacteria in adults and children over 1 years of age. |
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
 ××× ×¢××× ×ר××¤× Â |
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ××××××ר×× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | COOPER PHARMACEUTICALS S.A. , GREECE |
| ×©× ××¢× ×ר×ש×× | MEDOMIE PHARMA LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 2/2023. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 04/06/2025 |
השינוי האחרון נעשה בֹ־4 ביוני 2025 ב־13:49